SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
-15.81%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
AUM
$478M
AUM Growth
+$478M
Cap. Flow
+$27.4M
Cap. Flow %
5.73%
Top 10 Hldgs %
73.56%
Holding
41
New
2
Increased
3
Reduced
3
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRME icon
26
Prime Medicine
PRME
$578M
$2.78M 0.58% 540,304
DAWN icon
27
Day One Biopharmaceuticals
DAWN
$769M
$2.71M 0.57% 196,425
IMTX icon
28
Immatics
IMTX
$619M
$2.3M 0.48% 198,000 -198,000 -50% -$2.3M
JANX icon
29
Janux Therapeutics
JANX
$1.37B
$1.89M 0.4% 45,052 -135,155 -75% -$5.66M
TERN icon
30
Terns Pharmaceuticals
TERN
$609M
$1.38M 0.29% 202,348
IGMS
31
DELISTED
IGM Biosciences
IGMS
$1.06M 0.22% 154,664
BOLT icon
32
Bolt Biotherapeutics
BOLT
$9.85M
$787K 0.16% 1,049,153
LYRA icon
33
Lyra Therapeutics
LYRA
$11.5M
$769K 0.16% 2,780,261
ACRS icon
34
Aclaris Therapeutics
ACRS
$209M
$766K 0.16% 696,171
VIRX
35
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$375K 0.08% 689,709
ALLK
36
DELISTED
Allakos
ALLK
$172K 0.04% 172,089
KRON
37
DELISTED
Kronos Bio
KRON
$96.9K 0.02% 78,131
KLRS
38
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$59.6K 0.01% 82,336
NUVB.WS icon
39
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$21.3K ﹤0.01% 133,333
SRZNW icon
40
Surrozen, Inc. Warrant
SRZNW
$71.6K
$1.66K ﹤0.01% 99,999
ADVM icon
41
Adverum Biotechnologies
ADVM
$64.6M
-291,666 Closed -$4.12M